Ipilimumab-Induced Orbital Inflammation Resembling Graves Disease With Subsequent Development of Systemic Hyperthyroidism From CTLA-4 Receptor Suppression

被引:20
作者
Borodic, Gary E. [1 ]
Hinkle, David [1 ]
机构
[1] Harvard Univ, Sch Med, Quincy, MA USA
关键词
D O I
10.1097/IOP.0000000000000033
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:83 / 83
页数:1
相关论文
共 4 条
  • [1] Drug-Induced Graves Disease From CTLA-4 Receptor Suppression
    Borodic, Gary
    Hinkle, David M.
    Cia, Yihong
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2011, 27 (04) : E87 - E88
  • [2] Reply re: "Drug-induced Graves Disease From CTLA-4 Receptor Suppression"
    Borodic, Gary E.
    Hinkle, David M.
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2013, 29 (03) : 241 - 241
  • [3] Orbital myositis associated with ipilimumab
    Lecouflet, M.
    Verschoore, M.
    Giard, C.
    Gohier, P.
    Le Corre, Y.
    Milea, D.
    Martin, L.
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2013, 140 (6-7): : 448 - 451
  • [4] Re: "Drug-induced Graves Disease From CTLA-4 Receptor Suppression"
    Sohrab, Mahsa A.
    Desai, Rajen U.
    Chambers, Christopher B.
    Lissner, Gary S.
    [J]. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2013, 29 (03) : 239 - 240